InnovAge Holding (INNV) Hisse Özeti
InnovAge Holding Corp. evlerinde ve topluluklarında bağımsız olarak yaşamak için bakıma ve desteğe ihtiyaç duyan yaşlılar için bir dizi tıbbi ve yardımcı hizmeti yönetir ve sağlar. Daha fazla detay
| Kar Tanesi Skoru | |
|---|---|
| Değerleme | 3/6 |
| Gelecekteki Büyüme | 4/6 |
| Geçmiş Performans | 0/6 |
| Finansal Sağlık | 5/6 |
| Temettüler | 0/6 |
Ödüller
Risk Analizi
Risk kontrollerimizden INNV için herhangi bir risk tespit edilmedi.
INNV Community Fair Values
Create NarrativeSee what 12 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
InnovAge Holding Corp. Rakipler
Fiyat Geçmişi ve Performans
| Tarihsel hisse senedi fiyatları | |
|---|---|
| Güncel Hisse Fiyatı | US$10.85 |
| 52 Haftanın En Yüksek Seviyesi | US$12.64 |
| 52 Haftanın En Düşük Seviyesi | US$3.18 |
| Beta | 0.40 |
| 1 Aylık Değişim | -9.51% |
| 3 Aylık Değişim | 33.62% |
| 1 Yıllık Değişim | 214.49% |
| 3 Yıllık Değişim | 53.47% |
| 5 Yıllık Değişim | -32.86% |
| Halka arzdan bu yana değişim | -55.17% |
Son Haberler & Güncellemeler
Anlatı Güncellemesi • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.Anlatı Güncellemesi • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.Anlatı Güncellemesi • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Recent updates
Anlatı Güncellemesi • Jun 19
INNV: Unchanged Assumptions And 2026 Guidance Will Restrain Stock Upside
Analysts have kept their fair value estimate for InnovAge Holding steady at $7.00 per share, reflecting largely unchanged assumptions for the discount rate, revenue growth, profit margin, and future P/E in their updated price target work. What’s in the News for InnovAge Holding InnovAge Holding issued updated corporate guidance for fiscal 2026, providing investors with a more detailed view of expected performance.Anlatı Güncellemesi • Jun 05
INNV: 2026 Guidance And Margin Outlook Will Shape Balanced Risk Reward
Analysts have kept their price target on InnovAge Holding steady at $7.00, pointing to slightly lower modeled revenue growth, a higher projected profit margin, and a modestly reduced future P/E assumption as key drivers of the updated view. What's in the News InnovAge Holding raised earnings guidance for fiscal 2026, with total revenues now expected in a range of US$950 million to US$975 million.Anlatı Güncellemesi • May 16
INNV: Updated Modeling And 2026 Guidance Will Shape Balanced Risk Reward Outlook
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling related to fair value, discount rate, growth expectations, profit margins, and future P/E assumptions. Analyst Commentary JPMorgan raised its price target on InnovAge Holding to US$7 from US$5 after updating its model, while maintaining an Underweight rating on the stock.Anlatı Güncellemesi • Apr 20
INNV: Updated Modeling And 2026 Guidance Will Likely Limit Future Share Upside
Analysts raised their price target on InnovAge Holding to $7 from $5, citing updated company modeling as the key driver of the change. Analyst Commentary The move to a US$7 price target signals that at least one major firm sees enough change in the underlying assumptions to justify a higher valuation for InnovAge Holding, even while keeping a cautious stance on the stock.Anlatı Güncellemesi • Apr 05
INNV: Updated Modeling And 2026 Guidance Will Likely Temper Upside Expectations
Analysts have raised their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions that incorporate refined views on fair value, discount rate, revenue growth, profit margin, and future P/E. Analyst Commentary JPMorgan's updated price target signals a fresh look at InnovAge Holding's valuation framework, even as the firm maintains an Underweight stance.Anlatı Güncellemesi • Mar 22
INNV: Raised Outlook And Model Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated models that refine assumptions around fair value, discount rate, revenue growth, profit margin and future P/E. Analyst Commentary Bullish Takeaways Bullish analysts view the lift in the price target to $7 as a sign that updated assumptions on fair value and discount rates support a higher implied equity valuation.Anlatı Güncellemesi • Mar 08
INNV: Raised Outlook And P/E Assumptions Will Likely Prove Overly Optimistic
Analysts have lifted their price target on InnovAge Holding to $7 from $5, reflecting updated modeling assumptions around fair value, discount rate, revenue growth, profit margin and future P/E that collectively support a modestly higher valuation framework. Analyst Commentary Bullish Takeaways Bullish analysts see the move to a US$7 price target as recognition that updated fair value work supports a somewhat higher valuation range than before.Seeking Alpha • Feb 23
InnovAge: The Headwinds Are Priced In, The Growth May Not Be
Summary InnovAge Holding Corp. delivers strong operational execution, driving significant revenue and margin expansion through its PACE model for elderly care. INNV’s revenue rose 14.7% year-over-year, fueled by participant growth and capitation rate adjustments across established centers. Disciplined cost management and SG&A reductions have expanded center-level contribution margin to 22% and adjusted EBITDA margin to 9.2%. Despite Medicaid eligibility headwinds, INNV’s improved processes and in-house pharmacy transition support a bullish outlook on sustainability and leverage. Read the full article on Seeking AlphaAnlatı Güncellemesi • Feb 21
INNV: Future Margin Assumptions Will Likely Prove Overly Optimistic
Analysts have revised their price target on InnovAge Holding, reflecting updated views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions. Together, these factors result in a new target of $7.00, up from $5.00.Analiz Makalesi • Feb 06
Earnings Beat: InnovAge Holding Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
InnovAge Holding Corp. ( NASDAQ:INNV ) investors will be delighted, with the company turning in some strong numbers...Analiz Makalesi • Jan 17
InnovAge Holding Corp.'s (NASDAQ:INNV) Price In Tune With Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.9x right...Analiz Makalesi • Dec 13
InnovAge Holding (NASDAQ:INNV) Might Be Having Difficulty Using Its Capital Effectively
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...Analiz Makalesi • Nov 07
InnovAge Holding Corp. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
As you might know, InnovAge Holding Corp. ( NASDAQ:INNV ) just kicked off its latest quarterly results with some very...Analiz Makalesi • Nov 03
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Analiz Makalesi • Sep 10
Improved Revenues Required Before InnovAge Holding Corp. (NASDAQ:INNV) Stock's 32% Jump Looks Justified
InnovAge Holding Corp. ( NASDAQ:INNV ) shareholders would be excited to see that the share price has had a great month...Analiz Makalesi • Jul 08
Health Check: How Prudently Does InnovAge Holding (NASDAQ:INNV) Use Debt?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Yeni Anlatı • May 29
Expanding US Senior Care Integration Will Drive Healthcare Transformation
Enrollment growth and efficient geographic expansion are positioning the company for sustained revenue gains and scalable growth.Analiz Makalesi • May 09
After Leaping 36% InnovAge Holding Corp. (NASDAQ:INNV) Shares Are Not Flying Under The Radar
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 36% after a shaky period...Analiz Makalesi • Apr 09
Is InnovAge Holding (NASDAQ:INNV) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analiz Makalesi • Feb 06
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.6x may look like a pretty appealing...Analiz Makalesi • Nov 07
Investors Aren't Entirely Convinced By InnovAge Holding Corp.'s (NASDAQ:INNV) Revenues
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x seems...Analiz Makalesi • Aug 20
Is InnovAge Holding (NASDAQ:INNV) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analiz Makalesi • Jun 28
InnovAge Holding Corp.'s (NASDAQ:INNV) Shares Leap 30% Yet They're Still Not Telling The Full Story
InnovAge Holding Corp. ( NASDAQ:INNV ) shares have had a really impressive month, gaining 30% after a shaky period...Analiz Makalesi • May 07
Sentiment Still Eluding InnovAge Holding Corp. (NASDAQ:INNV)
It's not a stretch to say that InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 0.8x right...Analiz Makalesi • Mar 15
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Analiz Makalesi • Jan 06
Market Still Lacking Some Conviction On InnovAge Holding Corp. (NASDAQ:INNV)
There wouldn't be many who think InnovAge Holding Corp.'s ( NASDAQ:INNV ) price-to-sales (or "P/S") ratio of 1.1x is...Hissedar Getirileri
| INNV | US Healthcare | US Pazar | |
|---|---|---|---|
| 7D | -8.1% | -4.1% | 4.9% |
| 1Y | 214.5% | 41.8% | 21.3% |
Getiri vs. Endüstri: INNV geçen yıl % 41.8 oranında getiri sağlayan US Healthcare sektörünü aştı.
Getiri vs Piyasa: INNV geçen yıl % 21.3 oranında getiri sağlayan US Piyasasını aştı.
Fiyat Oynaklığı
| INNV volatility | |
|---|---|
| INNV Average Weekly Movement | 7.4% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in US Market | 16.3% |
| 10% least volatile stocks in US Market | 3.1% |
İstikrarlı Hisse Senedi Fiyatı: INNV son 3 ayda US piyasasına kıyasla önemli bir fiyat oynaklığı yaşamadı.
Zaman İçindeki Volatilite: INNV 'nin haftalık oynaklığı ( 7% ) son bir yıldır istikrarlı seyretti.
Şirket Hakkında
| Kuruldu | Çalışanlar | CEO | Web sitesi |
|---|---|---|---|
| 1989 | 2,440 | Patrick Blair | www.innovage.com |
InnovAge Holding Corp. evlerinde ve topluluklarında bağımsız olarak yaşamak için bakıma ve desteğe ihtiyaç duyan yaşlılar için bir dizi tıbbi ve yardımcı hizmeti yönetir ve sağlar. İşlerini Yaşlılar için Her Şey Dahil Bakım Programı (PACE) yaklaşımıyla yönetmektedir. Şirket ayrıca vasıflı, vasıfsız ve kişisel bakımdan oluşan evde bakım hizmetleri; birinci basamak bakım, fizik tedavi, mesleki terapi, konuşma terapisi, diş hizmetleri, ruh sağlığı ve psikiyatrik hizmetler, yemekler ve aktiviteler gibi merkez içi hizmetler; PACE merkezine ve üçüncü taraf tıbbi randevulara ulaşım ve bakım yönetimi sunmaktadır.
InnovAge Holding Corp. Temel Bilgiler Özeti
| INNV temel i̇stati̇sti̇kler | |
|---|---|
| Piyasa değeri | US$1.52b |
| Kazançlar(TTM) | -US$11.61m |
| Gelir(TTM) | US$949.17m |
1.6x
P/S Oranı-126.9x
F/K OranıINNV aşırı değerli mi?
Gerçeğe Uygun Değer ve değerleme analizine bakınızKazanç ve Gelir
| INNV gelir tablosu (TTM) | |
|---|---|
| Gelir | US$949.17m |
| Gelir Maliyeti | US$300.41m |
| Brüt Kâr | US$648.76m |
| Diğer Giderler | US$660.37m |
| Kazançlar | -US$11.61m |
Son Raporlanan Kazançlar
Mar 31, 2026
Sonraki Kazanç Tarihi
n/a
| Hisse başına kazanç (EPS) | -0.086 |
| Brüt Marj | 68.35% |
| Net Kâr Marjı | -1.22% |
| Borç/Özkaynak Oranı | 22.4% |
INNV uzun vadede nasıl bir performans gösterdi?
Geçmiş performansı ve karşılaştırmayı görünŞirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/08/04 16:21 |
| Gün Sonu Hisse Fiyatı | 2026/08/04 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2025/06/30 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
InnovAge Holding Corp. 14 Bu analistlerden 3, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Vikram Kesavabhotla | Baird |
| Steven Valiquette | Barclays |
| Sarah James | Barclays |